Immunotherapy’s Benefits for Colon Cancer Survivors Continue Long After Treatment Stops
WEDNESDAY, Dec. 20, 2023 (HealthDay News) — Many patients with advanced colon cancers who are successfully treated with immunotherapy and then stop those treatments appear to face little risk of tumor progression two years later. That’s the main finding from a study that tracked outcomes for 64 people treated forContinue Reading